Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $15
ClearPoint Neuro Price Target Raised to $15.00/Share From $11.00 by Lake Street
ClearPoint Neuro Analyst Ratings
Lake Street Maintains Buy on ClearPoint Neuro, Raises Price Target to $15
Stifel Nicolaus Keeps Their Buy Rating on ClearPoint Neuro (CLPT)
B. Riley Adjusts Price Target on ClearPoint Neuro to $10.50 From $10, Maintains Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Remains a Buy on ClearPoint Neuro (CLPT)
B.Riley Financial Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $10
Lake Street Keeps Their Buy Rating on ClearPoint Neuro (CLPT)
ClearPoint Neuro (CLPT) Receives a Buy From Lake Street
ClearPoint Neuro Poised for Growth: Strong Buy Rating Justified Amidst Market Dip
ClearPoint Neuro Analyst Ratings
Lake Street Sticks to Their Buy Rating for ClearPoint Neuro (CLPT)
Analysts Are Bullish on These Healthcare Stocks: Achieve Life Sciences (ACHV), ClearPoint Neuro (CLPT)
Analysts Are Bullish on These Healthcare Stocks: ClearPoint Neuro (CLPT), Apollo Medical Holdings (AMEH)
ClearPoint Neuro's Strategic Growth and Regulatory Milestones Bolster Buy Rating
Analysts' Top Healthcare Picks: ClearPoint Neuro (CLPT), Semler Scientific (SMLR)
Stifel Nicolaus Remains a Buy on ClearPoint Neuro (CLPT)
No Data
No Data